Related Experiment Videos
[Contribution of animal experiments in the problem of a long-term indomethacin therapy in advanced nephron loss]
B Hortian1, P W Wüstenberg, H Klinkmann
1Abteilung Pathophysiologie, Wilhelm-Pieck-Universität Rostock.
Abstract:
Residual nephrons are subject to compensatory adaptation at which the glomerular hyperfiltration and convection of macromolecules (proteins) are of pathogenic character in the progression of nephropathy. The influence of indomethacin at dosages of 2 or 3 mg/kg body weight/day was investigated in long-term feeding trials (8 months) on inbred female Wistar rats after unilateral nephrectomy and additional resection of both kidney poles. The results show a significant deterioration of vital prognosis under indomethacin medication independently of the dosage.
Insights
Indomethacin medication worsened survival in rats with reduced kidney mass, regardless of dose. This highlights the risks of non-steroidal anti-inflammatory drugs in chronic kidney disease patients.
Area of Science:
- Nephrology
- Pharmacology
- Toxicology
Background:
- Compensatory adaptation in residual nephrons involves glomerular hyperfiltration and protein convection, which can be pathogenic in nephropathy.
- Unilateral nephrectomy and kidney pole resection create a model of reduced renal mass.
Purpose of the Study:
- To investigate the long-term effects of indomethacin on survival in a rat model of reduced renal mass.
- To determine if indomethacin dosage influences its impact on prognosis.
Main Methods:
- Inbred female Wistar rats underwent unilateral nephrectomy and bilateral kidney pole resection.
- Animals received indomethacin at 2 or 3 mg/kg body weight/day for 8 months.
- Survival rates were monitored to assess vital prognosis.
Main Results:
- Indomethacin administration led to a significant deterioration in vital prognosis.
- The negative impact on survival was observed independently of the indomethacin dosage used.
- The study demonstrated adverse effects of indomethacin in a model of chronic kidney disease.
Conclusions:
- Indomethacin poses a significant risk to survival in individuals with reduced kidney mass.
- Non-steroidal anti-inflammatory drugs should be used with extreme caution in patients with chronic kidney disease.
- Further research is needed to understand the mechanisms behind indomethacin's detrimental effects in nephropathy.